European Archives - Page 281 of 1059 - European Medical Journal

Working Together to Tackle Cancer

Find out how Daiichi Sankyo scientists are uncovering new ways to address needs in cancer.

Does Earlier Age of Menarche Increase Diabetes Risk in Females?

New research has indicated that early menarche could be linked to an increased risk of developing Type 2 diabetes, and for those who do, the risk of having a stroke before 65 years of age is also increased.

Low Inflammatory Index Diets Could Reduce Type 2 Diabetes Risk

According to research, low-inflammatory diets could influence the progression from prediabetes to Type 2 diabetes. Read for more details.

Patients with Myeloma Have Poorer Outcomes in Real-World Setting

Researchers found that real-world outcomes for individuals who received the standard treatment regimens for multiple myeloma were significantly poorer than outcomes reported in clinical trials.

New and Improved Method to Test Platelet Function

A research team in the USA found a new experimental technique to test platelet function that, by requiring only a drop of blood, may be faster, easier, and more accurate than current methods. Read more.

Nail Changes: When to Suspect an Underlying Disease

Watch our latest EMJ webinar, which explores nails as a sign of systemic disease. Expert Michela Starace, University of Bologna, Italy…

Spoonful of technology: Oct-Dec 2023

Dive into the top technology stories of the past few months as GOLD explores the funding landscape and the latest innovations in the health tech market

Get ready for Gen Z doctors

A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?

Is Percutaneous Kidney Biopsy Safe for Smaller Kidneys?

Percutaneous kidney biopsy has been shown to be a feasible and safe procedure when testing patients with small kidneys, according to new research. Read more.

Racial Differences in Arteriovenous Access After Haemodialysis

New research, presented by Melandrea Worsley, Baylor College of Medicine, Houston, Texas, USA, and her team, suggests that racial and ethnic differences exist in arteriovenous access use in patients 1 year after haemodialysis initiation.